ASHPOfficial

ASHP’s Executive Forum on Cold Chain Management convened virtually on April 19 to review the current state of pharmaceutical cold chain management in health systems. The event was the first in a series of executive forums on cold chain management and part of the ASHP Innovation Center’s efforts to influence innovation and digital transformation to advance the safe and effective use of medicines. This podcast explores key takeaways from the executive forum event and the importance of the pharmaceutical cold chain to public health needs. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

We will discuss the current FDA-approved first-line NCCN Category 1 treatment options for relapsed or stage IV clear cell RCC, specifically evaluating the various immunotherapy (IO) combination therapies, their clinical application, and considerations for choosing between available combinations. We will also review the side effect/toxicity profile and management strategies for each therapy. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The MAT Act has been introduced in the 117th congress and would eliminate the burdensome x waiver which requires that a health care practitioner apply for a separate waiver through the DEA to dispense certain narcotic drugs (e.g., buprenorphine) for substance use disorder treatment. The MAT Act would increase treatment access for patients to medication assisted treatment and make it easier for clinicians to provide substance use disorder treatment to their patients. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this feature from the 2021 Midyear Clinical Meeting, our content matter experts identify the challenges and share the solutions for transgender people navigating the healthcare system and discuss the clinical concerns and controversies in comprehensive medication management for transgender people. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode provides an overview of how healthcare providers may initiate transitions of care services. Speakers share both successes and challenges experienced when implementing their own transitions of care services as well as how they were able to overcome barriers. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recently updated the pneumococcal vaccination recommendations and guidelines to include two newly approved vaccines. The updated guidelines provide a more streamlined method for patients across age and risk groups. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast episode, Dr. Tristan Maiers, Dr. Alicia Mattson, and Dr. Kristen Baron discuss their respective articles entitled, “Impact of a pharmacist-led telehealth oral chemotherapy clinic”, “Description of telepharmacy services by emergency medicine pharmacists”, and “Evaluation of a remote hybrid staffing model for ambulatory clinical pharmacists in a pediatric health system during the COVID-19 pandemic”, which were published in the AJHP theme issue on Telehealth, with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode discusses strategies to improve engagement, emotional components of retention and job satisfaction, and methods to recognize the valuable role technicians provide in patient care. With the heightened national issue around healthcare burnout and how this impacts professional satisfaction and retention for pharmacy technicians this discussion provides insights how organizations have made improvements to support their pharmacy technicians. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

During this podcast, we will be talking with Tina Claypool. We will discuss her involvement with Kentucky Society of Health-System Pharmacists (KSHP) Women in Pharmacy Committee and the integration of students with state affiliates. This relationship is beneficial by encouraging professional growth, mentorship, and furthering the provision of pharmacy care. The audience will gain insight on inclusion and how to involve themselves with state affiliates. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Safety is at the forefront of all processes in the pharmacy department. ASHP has been a champion of safety since the organization originated more than 75 years ago. ASHP received funding from the Food and Drug Administration’s (FDA) Safe Use Initiative to develop and implement national standardized concentrations for IV and oral liquid medications. This is the first national inter-professional (physicians, pharmacists, nurses) initiative to standardize medication concentrations with the goal of reducing prescribing, dispensing, and medication errors for patients of all ages in settings ranging from hospital to home. This outstanding program, called Standardize 4 Safety, will have substantial downstream effects on safety, cost, efficiency, and error-reduction. Standardization will result in consolidated/converged product demand from hospitals, and more instances of ready-for-use drug preparations from manufacturers, simpler drug libraries, improvements to automatic drug recognition by infusion pumps, and improved clinical information system data exchange. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode looks at successful patient mental health support programs and the approaches the programs used to be successful. The moderator and guests discuss methodologies and strategies that will help listeners better understand how to implement a successful patient mental health support program at their site. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode is a special edition as part of ASHP’s recognition of Asian-American and Pacific Islander Heritage Month. This episode provides an engaging interview with three pharmacy leaders who have had successful careers and contributed significantly to health system professional associations. Binita Patel, Ashley Ramp, and Chris Scott will share their insights on their professional journeys as pharmacists and association leaders. This discussion includes the value of mentors, essentials for leading teams, growing influence, and achieving personal goals. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

With several choices for oral anticoagulation in Nonvalvular Atrial Fibrillation (NVAF), it is critical for pharmacists to be able to account for patient specific factors when selecting the most appropriate anticoagulant. To learn more, visit www.ashpadvantage.com/nvaf The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode provides an overview of vaping with an additional emphasis on use in the adolescent population. Topics will include an overview of vaping devices, changes in adolescent use over the past several years, and management of associated lung injury. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast episode, members of the New Practitioners Forum Career Development Advisory Group interview two pharmacy leaders on their perspectives of impostor syndrome and how it's impacted their personal and professional lives. The speakers help define impostor syndrome and provide words of wisdom to new practitioners and beyond when facing impostor syndrome. For additional resources on combatting impostor syndrome, check out the new resource outline developed the New Practitioners Forum. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Within a health system, student pharmacists on rotation often are responsible for making numerous clinical interventions. However, oftentimes students are not engaged in the clinical intervention documentation, and do not have the opportunity to practice and develop their documentation skills prior to going into independent practice as a pharmacist. In this episode of Educator Essentials, we talk about implementing a standardized method for tracking student pharmacist interventions in the inpatient setting. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Specialty pharmacy practice doesn’t always mean exotic or expensive drugs; it's often the work done to get those products paid for and ensure patient access and timely start of therapy. Members of this group outline what work really makes their team special and how they contribute to patient care. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode provides an overview of the available weight loss medications and walks through how to approach a patient case. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Medication excipients (often-referred to as inactive ingredients) provide several functions, such as serving as binders, disintegrants, solubilizers, preservatives, and/or assisting with pH adjustment. However, medication excipients may cause adverse events or allergic reactions in some patients. Several regulatory and technological gaps exist that hinder practitioners from preventing adverse events and allergic reactions related to these excipients. This podcast is intended to bring awareness to current regulatory and technological gaps associated with managing medication excipient allergies and intolerances, highlight common operational challenges involved with identifying and preventing medication excipient allergic reactions, and provide current “best practices” to address these issues. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode explores the intersection of clinical pain management and the relatively newer concept of “opioid stewardship” within the context of pharmacy practice. Listeners will receive an overview of institutional pain management and opioid stewardship programs, as well as learn how these conceptual frameworks for healthcare practice compare and contrast. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode will provide an overview of pharmacy informatics and how residency programs in this field can help learners prepare to become an informaticist. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join members from the ASHP Section of Inpatient Care Practitioners Compounding Section Advisory Group for a discussion on “Compounding Conundrums.” Each speaker will reflect on a recent challenge they have faced, briefly describe the challenge, and discuss how they addressed it. We aim to share innovative approaches to problems faced by our pharmacy peers, specifically those involved with or overseeing compounded sterile preparations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode explores leadership strategies and skills needed to stay relevant in healthcare. The speakers describe how they keep up with the changes in managing healthcare technology, as well as how ASHP has contributed to their ability to keep pace with these changes. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast episode, listeners will learn about the journey of few health-system specialty pharmacies and their need for accreditation to support their clinical services and operations. In addition, listeners will learn strategies to address ongoing maintenance and compliance of the standards set by the accrediting body before re-accreditation. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast episode, listeners will learn about the journey of few health-system specialty pharmacies and their need for accreditation to support their clinical services and operations. In addition, listeners will learn strategies to address ongoing maintenance and compliance of the standards set by the accrediting body before re-accreditation. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The ASHP Well-Being Ambassador Program (WBA) is a curriculum-based, virtual learning community that will empower local action, particularly in tribal, rural, and underserved areas, to mitigate occupational burnout in healthcare organizations. The work is being funded through a three-year grant from the Health Resources and Services Administration (HRSA) Health and Public safety Workforce Resiliency Training Program. Today’s podcast episode will discuss this opportunity. Learn more about becoming an ASHP well-being ambassador: https://wellbeing.ashp.org/wellbeing/well-being-ambassador-program The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast explores the introduction of the Equitable Community Access to Pharmacist Services Act (H.R. 7213) by Congress. Tom Kraus discusses what the bill does, how it will impact pharmacy, what is the path forward, and what ASHP members can do to advance the legislation. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast episode, we will explore development of interprofessional teams that embrace pharmacy learners. The goal is to help arm academic pharmacists with candid insights on how to approach providers and practices with creating and developing integrated pharmacy services. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Atrial fibrillation is the most common abnormal heart rhythm and has tripled in prevalence of the last 50 years. Approximately 20% of patients with atrial fibrillation may not even know that they have the arrhythmia. This podcast episode will provide insight into the importance of undiagnosed atrial fibrillation and will give practical tips to the pharmacist interested in developing a screening program for identifying undiagnosed atrial fibrillation. To learn more, visit www.ashpadvantage.com/nvaf The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast episode, Dr. William Anthony Hawkins, Dr. Charles (CJ) Wilson, and Dr. Michael Long discuss their article, “From Theory to Bedside: Implementation of Fluid Stewardship in a Medical ICU Pharmacy Practice,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Jessica Spangler, PharmD is a PGY-1 pharmacy resident who uses her passion for personal finance to educate others on social media. With over 300,000 followers, Jessica has turned this passion into an entrepreneurial venture on various social media platforms. Jessica will share how she got interested in both pharmacy and personal finance, and how she is using her knowledge and skills in both to reach her audience. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

One core outcome of a residency is learning how to precept. In this episode of Educator Essentials, we talk about how incorporating the four preceptor roles of Instructing, Modeling, Coaching, and Facilitating throughout the resident’s year can increase their precepting confidence and success. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

During this podcast episode, the faculty will delve deeper into the integration of central fill into the business of their respective health systems, including key objectives and whether those were met. Considerations for the buildout, taking into consideration the proximity to the health-system’s pharmacies will also be discussed. The podcast will conclude with discussion of staff reaction to central fill during all phases of the process (pre-implementation, during implementation, and post-implementation). The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, our content matter expert reviews the literature on measurement, treatment and prophylaxis recommendations related to anticoagulation in critically ill COVID-19 patients and reviews management considerations for special ICU populations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In 2018, state health departments received funding to support diabetes and cardiovascular disease prevention and management efforts under a 5-year cooperative agreement with the Centers for Disease Control and Prevention (CDC). The Alaska Department of Health and Social Services Section of Chronic Disease Prevention and Health Promotion partnered with the Alaska Pharmacists Association (AKPhA) in funding the Sustainable Education and Training Model under Pharmacist Provider Reimbursement (SETMuPP) program. This podcast episode summarizes the initial accomplishments and provides a framework for other groups invested in provision and sustainability of pharmacist-provided health services. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode from the 2021 Midyear Clinical Meeting, our content matter expert evaluates the literature and explores the role that immunomodulators and antivirals may (or may not play) for the management of COVID-19 infection in the critically ill. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This presentation focuses on outpatient infectious diseases topics, specifically focusing on sexually transmitted infections (STI) treatment strategies. Content experts discuss recent guideline updates, changes in recommended therapies, dosing strategies, and other clinical considerations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast episode, listeners will learn about the journey of few health-system specialty pharmacies and the need for the accreditation to support their clinical services and operations. In addition, listeners will also learn on how to continue the ongoing maintenance and compliance of the standards set by the accrediting body before the re-accreditation. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will overview real world examples of technician retention and recognition programs, and will feature an interview with technician leaders from two institutions to gain insight to their experiences and preferences related to technician retention and recognition programs. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP is committed to advancing the field of pharmacogenomics and educating members on the impact of pharmacogenomics testing, dosing, and monitoring of medications on improved health outcomes. This podcast explores the new Pharmacogenomics Accelerator program from ASHP in partnership with the University of Minnesota College of Pharmacy including program goals, value to participants, enrollment process, and more. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, content matter experts evaluate primary literature and guideline recommendations for the managing sedation and analgesia in critically ill patients hospitalized with COVID-19. We also review the role post ICU clinics play in managing these patients after discharge. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us as we hear from Jessica Perlo, Senior Director at the Institute for Healthcare Improvement. As an Improvement Advisor, Jessica has led many initiatives in IHI to address burnout and restore individual wellness including a focus on restoring joy to the health care workforce, and the Healthcare Workforce Rescue Package from the All In Well-Being Campaign. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode is an interview with Dr. Christopher Jones, the Acting Director of the U.S. Centers for Disease Control & Prevention’s Injury Center, about CDC’s new draft clinical practice guideline (CPG) for prescribing opioids and what it means for current practice. Dr. Jones walks listeners through changes to the CPG from the 2016 version, the process for revising the CPG, and the types of input from members that will best assist CDC as they finalize the CPG. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacist prescribing continues to be a key area for advocacy, especially with the onset of the COVID-19 pandemic. This podcast episode highlights a rural health system’s model to empower pharmacist prescribing of COVID-19 oral antiviral medications and addresses challenges in providing optimal patient care in the small and rural hospital setting. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode discusses social determinants of health in pharmacy practice and training. The speakers address the significance of social determinants of health in patient care as well as the importance of introducing these principles early in pharmacy education. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Medications utilized in rapid sequence intubation vary in preference and dosing in special populations. This podcast episode focuses on RSI in obese patients. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

As SGLT2-inhibitors become more relevant in multiple disease states with recent data surrounding HFpEF, we will discuss the real world implementation of the medication. We will also review how cost and formularies may affect our decision. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

From the 2021 Midyear Clinical Meeting and planned in cooperation with Section of Ambulatory Care Practitioners, this session explores the current status of COVID-19 vaccines in the United States, summarizes the ideal pharmacist role in immunization delivery and how to overcome barriers to COVID-19 administration. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode highlights a unique and innovative virtual shadowing program for pre-health students developed by the University of Florida Department of Neurology. Members of the ASHP New Practitioners Forum chat with founders of the Medi-Gators Virtual Shadowing Program to gather their insights and lessons learned when developing the program to improve access to shadowing, mentorship, and other health-related opportunities for all students. Learn more about the Medi-Gators Virtual Shadowing Program here: https://neurology.ufl.edu/divisions/neurocritical-care/medi-gators-virtual-shadowing-program/ The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Hear experts discuss the FDA’s recent Complete Response Letter CRL regarding Takeda’s budesonide oral solution for eosinophilic esophagitis (EoE), what therapies are in the pipeline for EoE and their potential role in therapy. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.